Literature DB >> 28574060

Neurodevelopmental disorders: Metformin - a therapeutic option for fragile X syndrome?

Heather Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28574060     DOI： 10.1038/nrneurol.2017.82

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Metformin ameliorates core deficits in a mouse model of fragile X syndrome.

Authors:  Ilse Gantois; Arkady Khoutorsky; Jelena Popic; Argel Aguilar-Valles; Erika Freemantle; Ruifeng Cao; Vijendra Sharma; Tine Pooters; Anmol Nagpal; Agnieszka Skalecka; Vinh T Truong; Shane Wiebe; Isabelle A Groves; Seyed Mehdi Jafarnejad; Clément Chapat; Elizabeth A McCullagh; Karine Gamache; Karim Nader; Jean-Claude Lacaille; Christos G Gkogkas; Nahum Sonenberg
Journal:  Nat Med       Date:  2017-05-15       Impact factor: 53.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.